New Report Available: Argentina Pharmaceuticals & Healthcare Report Q4 2014
The Argentine economy is still reeling from the January 2014 currency devaluation. Soaring inflation and stringent drug pricing controls will continue to discourage investment and erode the growth of the country's pharmaceuticalmarket.More foreignpharmaceutical companies will cease their local operations, if the hostile business environment is worsened.
View full press release